Seed VC · France
AdBio invests in and develops early-stage startups in life sciences across Europe, working to identify promising therapeutic innovations and grow sustainable startups together with scientific founders and academic institutions.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Healthcare providers, Patients
Geography
Europe, France, Spain, Belgium, Germany, UK
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
AdBio Technologies (ex Advent France Biotechnology) writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks AdBio Technologies (ex Advent France Biotechnology) alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. AdBio Technologies (ex Advent France Biotechnology) is one of them, and we'll tell you exactly where they sit in your top 100.